Delayed
Hong Kong S.E.
04:08:17 2024-05-07 am EDT
|
5-day change
|
1st Jan Change
|
0.67
HKD
|
+1.52%
|
|
+3.08%
|
-17.28%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
846.1
|
756.8
|
480.9
|
367.9
|
275.9
|
273.3
|
Enterprise Value (EV)
1 |
451.1
|
440.1
|
242.3
|
112
|
8.033
|
-9.82
|
P/E ratio
|
13.2
x
|
10.5
x
|
-2.9
x
|
38.3
x
|
30.4
x
|
-8.94
x
|
Yield
|
4.5%
|
5.03%
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.84
x
|
0.62
x
|
0.53
x
|
0.52
x
|
0.31
x
|
0.39
x
|
EV / Revenue
|
0.45
x
|
0.36
x
|
0.27
x
|
0.16
x
|
0.01
x
|
-0.01
x
|
EV / EBITDA
|
3.9
x
|
3.5
x
|
9.43
x
|
6.04
x
|
0.28
x
|
9.55
x
|
EV / FCF
|
19.3
x
|
8.12
x
|
19.1
x
|
9.22
x
|
0.55
x
|
-0.36
x
|
FCF Yield
|
5.17%
|
12.3%
|
5.24%
|
10.8%
|
182%
|
-274%
|
Price to Book
|
0.9
x
|
0.79
x
|
0.64
x
|
0.48
x
|
0.35
x
|
0.38
x
|
Nbr of stocks (in thousands)
|
262,778
|
262,778
|
262,778
|
262,778
|
262,778
|
262,778
|
Reference price
2 |
3.220
|
2.880
|
1.830
|
1.400
|
1.050
|
1.040
|
Announcement Date
|
7/20/18
|
7/15/19
|
7/14/20
|
7/20/21
|
7/19/22
|
7/24/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,002
|
1,224
|
912.8
|
701.7
|
876.7
|
704.9
|
EBITDA
1 |
115.7
|
125.7
|
25.7
|
18.54
|
28.22
|
-1.028
|
EBIT
1 |
65.56
|
69.36
|
-32.18
|
-3.74
|
4.83
|
-23.69
|
Operating Margin
|
6.55%
|
5.67%
|
-3.53%
|
-0.53%
|
0.55%
|
-3.36%
|
Earnings before Tax (EBT)
1 |
74.71
|
84.75
|
-165.7
|
2.665
|
9.251
|
-34.35
|
Net income
1 |
64.06
|
72.12
|
-165.9
|
9.608
|
9.091
|
-30.56
|
Net margin
|
6.39%
|
5.89%
|
-18.18%
|
1.37%
|
1.04%
|
-4.33%
|
EPS
2 |
0.2438
|
0.2745
|
-0.6314
|
0.0366
|
0.0346
|
-0.1163
|
Free Cash Flow
1 |
23.33
|
54.17
|
12.69
|
12.15
|
14.6
|
26.93
|
FCF margin
|
2.33%
|
4.43%
|
1.39%
|
1.73%
|
1.66%
|
3.82%
|
FCF Conversion (EBITDA)
|
20.17%
|
43.11%
|
49.37%
|
65.53%
|
51.73%
|
-
|
FCF Conversion (Net income)
|
36.42%
|
75.11%
|
-
|
126.45%
|
160.56%
|
-
|
Dividend per Share
2 |
0.1450
|
0.1450
|
-
|
-
|
-
|
-
|
Announcement Date
|
7/20/18
|
7/15/19
|
7/14/20
|
7/20/21
|
7/19/22
|
7/24/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
395
|
317
|
239
|
256
|
268
|
283
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
23.3
|
54.2
|
12.7
|
12.1
|
14.6
|
26.9
|
ROE (net income / shareholders' equity)
|
6.87%
|
7.67%
|
-19.4%
|
1.25%
|
1.12%
|
-4.06%
|
ROA (Net income/ Total Assets)
|
3.66%
|
3.7%
|
-1.79%
|
-0.22%
|
0.29%
|
-1.49%
|
Assets
1 |
1,749
|
1,947
|
9,264
|
-4,318
|
3,174
|
2,049
|
Book Value Per Share
2 |
3.570
|
3.630
|
2.870
|
2.930
|
2.970
|
2.750
|
Cash Flow per Share
2 |
1.490
|
1.370
|
1.180
|
1.210
|
1.230
|
1.250
|
Capex
1 |
54.1
|
62
|
54.5
|
24.8
|
16.7
|
9.31
|
Capex / Sales
|
5.4%
|
5.07%
|
5.98%
|
3.53%
|
1.9%
|
1.32%
|
Announcement Date
|
7/20/18
|
7/15/19
|
7/14/20
|
7/20/21
|
7/19/22
|
7/24/23
|
|
1st Jan change
|
Capi.
|
---|
| -17.28% | 22.19M | | +12.78% | 96.65B | | +11.70% | 39.49B | | -1.26% | 18.37B | | -13.68% | 2.42B | | -10.21% | 1.52B | | +24.72% | 1.2B | | -33.16% | 772M | | -35.31% | 739M | | -7.40% | 658M |
Glasses, Spectacles & Contact Lenses
|